Form 4: Synopsys CFO Shelagh Glaser Executes Stock Options and Sells Shares Under Pre-Arranged Trading Plan

Synopsys Inc.'s Chief Financial Officer, Shelagh Glaser, exercised stock options and subsequently sold a total of 7,310 shares of common stock on June 6, 2025, as part of a Rule 10b5-1 trading plan.

Summary

• Shelagh Glaser, the Chief Financial Officer of Synopsys Inc. (SNPS), reported transactions involving the company's common stock.
• On June 6, 2025, Ms. Glaser exercised non-qualified stock options to acquire a total of 7,310 shares of common stock.
• Specifically, 2,086 shares were acquired at an exercise price of $354.45 per share, and 5,224 shares were acquired at an exercise price of $348.17 per share.
• Concurrently, Ms. Glaser sold all 7,310 shares acquired through the option exercises at a weighted average sale price of $485.7194 per share.
• The sales were executed in multiple transactions with prices ranging from $483.38 to $487.95.
• These transactions were conducted pursuant to a Rule 10b5-1 trading plan adopted on January 13, 2025.
• Following these transactions, Ms. Glaser's direct beneficial ownership of Synopsys common stock is 15,291 shares.
• Remaining derivative securities include 15,673 non-qualified stock options exercisable at $348.17 and 7,452 non-qualified stock options exercisable at $354.45.

Sentiment

Score: 5

Explanation: The sentiment is neutral. While insider selling can sometimes be viewed negatively, the fact that these transactions were conducted under a pre-arranged Rule 10b5-1 plan makes them routine and expected, mitigating any negative implications. It primarily reflects personal financial planning rather than a change in company outlook.

Positives

• The exercise of stock options indicates that the company's stock price was significantly above the option exercise prices, allowing the CFO to realize substantial gains.
• The transactions were conducted under a pre-arranged Rule 10b5-1 trading plan, which demonstrates a structured and compliant approach to insider stock transactions, reducing concerns about opportunistic selling.

Negatives

• The sale of shares by a key executive, even if pre-planned, represents a reduction in their direct equity stake in the company, which some investors might interpret as a lack of conviction, though this is often for personal financial planning.

Future Outlook

This Form 4 filing does not contain any forward-looking statements or guidance regarding the company's future performance or outlook.

Industry Context

This filing is a routine disclosure of insider stock transactions and does not provide information directly related to broader industry trends or competitive landscape. It reflects standard equity compensation practices within the technology sector.

Stakeholder Impact

• Shareholders: The sale of shares by a CFO, even if planned, slightly increases the public float and can be perceived as a minor reduction in insider alignment, though the impact is generally minimal for routine 10b5-1 sales.
• Employees: No direct impact mentioned.

Key Dates

Keywords

Synopsys, SNPS, Form 4, Insider Trading, Stock Options, Beneficial Ownership, CFO, Rule 10b5-1 Plan, Equity Compensation